• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IgG N-糖基化在冠状动脉疾病中发生改变。

IgG N-Glycosylation Is Altered in Coronary Artery Disease.

机构信息

Department of Biotechnology, University of Rijeka, 51000 Rijeka, Croatia.

Genos Glycoscience Research Laboratory, 10000 Zagreb, Croatia.

出版信息

Biomolecules. 2023 Feb 16;13(2):375. doi: 10.3390/biom13020375.

DOI:10.3390/biom13020375
PMID:36830744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9953309/
Abstract

Coronary artery disease (CAD) is the most common cardiovascular disease (CVD), and previous studies have shown a significant association between N-glycosylation, a highly regulated posttranslational modification, and the development of atherosclerotic plaques. Our aim was to determine whether the N-glycome of immunoglobulin G (IgG) is associated with CAD, as N-glycans are known to alter the effector functions of IgG, which may enhance the inflammatory response in CAD. Therefore, in this study, we isolated IgG from subjects with coronary atherosclerosis (CAD+) and from subjects with clean coronaries (CAD-). The purified IgGs were denatured and enzymatically deglycosylated, and the released and fluorescently labelled N-glycans were analysed by ultra-high performance liquid chromatography based on hydrophilic interactions with fluorescence detection (HILIC-UHPLC-FLR). Sex-stratified analysis of 316 CAD- and 156 CAD+ cases revealed differences in IgG N-glycome composition. The most notable differences were observed in women, where the presence of sialylated N-glycan structures was negatively associated with CAD. The obtained chromatograms provide insight into the IgG N-glycome composition in CAD as well as the biomarker potential of IgG N-glycans in CAD.

摘要

冠状动脉疾病(CAD)是最常见的心血管疾病(CVD),先前的研究表明,高度调控的翻译后修饰 N-糖基化与动脉粥样硬化斑块的发展之间存在显著关联。我们的目的是确定 IgG 的 N-聚糖是否与 CAD 相关,因为众所周知,N-聚糖可改变 IgG 的效应功能,从而增强 CAD 中的炎症反应。因此,在这项研究中,我们从冠状动脉粥样硬化(CAD+)患者和冠状动脉无病变(CAD-)患者中分离出 IgG。将纯化的 IgG 变性并酶促去糖基化,然后通过基于亲水相互作用与荧光检测的超高效液相色谱法(HILIC-UHPLC-FLR)分析释放和荧光标记的 N-聚糖。对 316 名 CAD-和 156 名 CAD+病例进行的性别分层分析显示,IgG N-聚糖组成存在差异。在女性中观察到最显著的差异,其中唾液酸化的 N-聚糖结构的存在与 CAD 呈负相关。所得色谱图提供了对 CAD 中 IgG N-聚糖组成的深入了解,以及 IgG N-聚糖在 CAD 中的生物标志物潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698b/9953309/7f0dff9a7ec8/biomolecules-13-00375-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698b/9953309/db86b6d013b1/biomolecules-13-00375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698b/9953309/7f0dff9a7ec8/biomolecules-13-00375-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698b/9953309/db86b6d013b1/biomolecules-13-00375-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/698b/9953309/7f0dff9a7ec8/biomolecules-13-00375-g002.jpg

相似文献

1
IgG N-Glycosylation Is Altered in Coronary Artery Disease.IgG N-糖基化在冠状动脉疾病中发生改变。
Biomolecules. 2023 Feb 16;13(2):375. doi: 10.3390/biom13020375.
2
Storage stability and HILIC-UHPLC-FLR analysis of immunoglobulin G N-glycome from saliva.唾液免疫球蛋白 G N-糖基化产物的存储稳定性和 HILIC-UHPLC-FLR 分析。
Anal Bioanal Chem. 2023 Nov;415(28):6985-6993. doi: 10.1007/s00216-023-04682-y. Epub 2023 Apr 14.
3
High-Throughput Analysis of the IgG N-Glycome by UPLC-FLR.采用超高效液相色谱-荧光检测法对IgG N-糖组进行高通量分析
Methods Mol Biol. 2017;1503:21-29. doi: 10.1007/978-1-4939-6493-2_3.
4
Changes of IgG -Glycosylation in Thyroid Autoimmunity: The Modulatory Effect of Methimazole in Graves' Disease and the Association With the Severity of Inflammation in Hashimoto's Thyroiditis.甲状腺自身免疫中 IgG-糖基化的变化:甲巯咪唑在格雷夫斯病中的调节作用及与桥本甲状腺炎炎症严重程度的关系。
Front Immunol. 2022 Mar 15;13:841710. doi: 10.3389/fimmu.2022.841710. eCollection 2022.
5
Robustness and repeatability of GlycoWorks RapiFluor-MS IgG N-glycan profiling in a long-term high-throughput glycomic study.在一项长期高通量糖组学研究中,GlycoWorks RapiFluor-MS IgG N-聚糖分析的稳健性和可重复性
Glycobiology. 2021 Sep 20;31(9):1062-1067. doi: 10.1093/glycob/cwab050.
6
High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations.高通量分离和 IgG 变异性的糖基化分析以及三种分离人群 IgG 聚糖的遗传力。
Mol Cell Proteomics. 2011 Oct;10(10):M111.010090. doi: 10.1074/mcp.M111.010090. Epub 2011 Jun 8.
7
Profiling of IgG N-glycome during mouse aging: Fucosylated diantennary glycans containing one Neu5Gc-linked LacNAc are associated with age.在小鼠衰老过程中 IgG N-糖基化组的分析:含有一个 Neu5Gc 连接的 LacNAc 的岩藻糖化二天线聚糖与年龄相关。
J Proteomics. 2020 Oct 30;229:103966. doi: 10.1016/j.jprot.2020.103966. Epub 2020 Sep 3.
8
N-Glycosylation Profiles of Immunoglobulin G and Future Cardiovascular Events.免疫球蛋白 G 的 N-糖基化谱与未来心血管事件。
Circ Res. 2024 Mar;134(5):e3-e14. doi: 10.1161/CIRCRESAHA.123.323623. Epub 2024 Feb 13.
9
Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.治疗性免疫球蛋白G Fc糖基化谱分析方法的比较 - 第2部分:质谱方法
MAbs. 2015;7(4):732-42. doi: 10.1080/19420862.2015.1045173.
10
Comprehensive analysis of -glycans in IgG purified from ferrets with or without influenza A virus infection.全面分析感染或未感染甲型流感病毒的雪貂 IgG 中的 - 聚糖。
J Biol Chem. 2018 Dec 14;293(50):19277-19289. doi: 10.1074/jbc.RA118.005294. Epub 2018 Oct 12.

引用本文的文献

1
The Association Between Neonatal Respiratory Distress Syndrome and Plasma IgG N-Glycosylation: A Case-Control Study.新生儿呼吸窘迫综合征与血浆IgG N-糖基化之间的关联:一项病例对照研究。
J Inflamm Res. 2025 May 21;18:6439-6451. doi: 10.2147/JIR.S524188. eCollection 2025.
2
Statin effects on immunoglobulin-G glycomic architecture and the link to cardiovascular disease.他汀类药物对免疫球蛋白G糖基结构的影响及其与心血管疾病的关联。
Res Sq. 2025 Mar 3:rs.3.rs-6112380. doi: 10.21203/rs.3.rs-6112380/v1.
3
Profiling of IgG N-glycosylation for axial spondyloarthritis and other rheumatic diseases.

本文引用的文献

1
Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease.免疫球蛋白 G N-糖基化特征与 2 型糖尿病及心血管疾病的发生。
Diabetes Care. 2022 Nov 1;45(11):2729-2736. doi: 10.2337/dc22-0833.
2
N-Glycosylation and Inflammation; the Not-So-Sweet Relation.N-糖基化与炎症;并非甜蜜的关系。
Front Immunol. 2022 Jun 27;13:893365. doi: 10.3389/fimmu.2022.893365. eCollection 2022.
3
Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement.
轴性脊柱关节炎及其他风湿性疾病的IgG N-糖基化分析
Arthritis Res Ther. 2025 Feb 22;27(1):37. doi: 10.1186/s13075-025-03505-y.
4
Immunoglobulin G glycosylation and its alterations in aging-related diseases.免疫球蛋白 G 糖基化及其在与衰老相关疾病中的改变。
Acta Biochim Biophys Sin (Shanghai). 2024 Aug 8;56(8):1221-1233. doi: 10.3724/abbs.2024137.
5
Recent advances in N-glycan biomarker discovery among human diseases.近年来人类疾病中 N-聚糖生物标志物的发现进展。
Acta Biochim Biophys Sin (Shanghai). 2024 Jun 21;56(8):1156-1171. doi: 10.3724/abbs.2024101.
6
The association between plasma IgG N-glycosylation and neonatal hypoxic-ischemic encephalopathy: a case-control study.血浆IgG N-糖基化与新生儿缺氧缺血性脑病的关联:一项病例对照研究。
Front Cell Neurosci. 2024 Mar 20;18:1335688. doi: 10.3389/fncel.2024.1335688. eCollection 2024.
7
Protein glycosylation in cardiovascular health and disease.心血管健康与疾病中的蛋白质糖基化
Nat Rev Cardiol. 2024 Aug;21(8):525-544. doi: 10.1038/s41569-024-00998-z. Epub 2024 Mar 18.
8
Association between immunoglobulin G N-glycosylation and lupus nephritis in female patients with systemic lupus erythematosus: a case-control study.免疫球蛋白 G N-糖基化与系统性红斑狼疮女性患者狼疮肾炎的相关性:一项病例对照研究。
Front Immunol. 2023 Sep 21;14:1257906. doi: 10.3389/fimmu.2023.1257906. eCollection 2023.
动脉粥样硬化性心血管疾病风险评估:美国预防心脏病学会临床实践声明
Am J Prev Cardiol. 2022 Mar 15;10:100335. doi: 10.1016/j.ajpc.2022.100335. eCollection 2022 Jun.
4
Immunoglobulin G glycome composition in transition from premenopause to postmenopause.从绝经前到绝经后过渡阶段的免疫球蛋白G糖组组成
iScience. 2022 Feb 10;25(3):103897. doi: 10.1016/j.isci.2022.103897. eCollection 2022 Mar 18.
5
Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study.高危患者为何会发生或不发生冠状动脉疾病?来自CAPIRE研究的代谢学见解。
Metabolites. 2022 Jan 27;12(2):123. doi: 10.3390/metabo12020123.
6
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
7
Global view of human protein glycosylation pathways and functions.人类蛋白糖基化途径和功能的全球视图。
Nat Rev Mol Cell Biol. 2020 Dec;21(12):729-749. doi: 10.1038/s41580-020-00294-x. Epub 2020 Oct 21.
8
Plasma -Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study.血浆糖链作为心血管代谢风险的新兴生物标志物:EPIC-Potsdam 队列研究的前瞻性研究。
Diabetes Care. 2020 Mar;43(3):661-668. doi: 10.2337/dc19-1507. Epub 2020 Jan 8.
9
Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties.人血浆脂蛋白的糖基化揭示了高度的多样性,这直接影响它们的功能特性。
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 May;1864(5):643-653. doi: 10.1016/j.bbalip.2019.01.005. Epub 2019 Jan 12.
10
Immunoglobulin G glycosylation in aging and diseases.免疫球蛋白 G 的糖基化在衰老和疾病中的作用。
Cell Immunol. 2018 Nov;333:65-79. doi: 10.1016/j.cellimm.2018.07.009. Epub 2018 Jul 23.